Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 06.06.2024
M1 Kliniken AG
M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
Group sales increase by 9.6% to EUR 84.7 million in Q1 2024
Growth driver Beauty segment: sales +18.2% and EBIT +50%
Strong operating performance should continue for the rest of the year
Berlin, June 6, 2024 – M1 Kliniken AG (ISIN: DE000A [ … ]
Thu, 06.06.2024
Aquis Stock Exchange
The following securities are suspended from trading on the Aquis Growth Market with effect from 08:00, 06/06/2024:
ChallengerX plc
Ordinary Shares
Symbol: CXS
ISIN: GB00BMD0WG01
The Regulation Department
Aquis Stock Exchange
Floor 2, 63 Queen Victoria Street, EC4N 4UA
Tel: 0203 597 6361
Email: aqseregulation@aquis.eu
Website: www.aquis.eu/aquis-sto [ … ]
Thu, 06.06.2024
Aquis Stock Exchange
The following securities are suspended from trading on the Aquis Growth Market with effect from 08:00, 06/06/2024:
ChallengerX plc
Ordinary Shares
Symbol: CXS
ISIN: GB00BMD0WG01
The Regulation Department
Aquis Stock Exchange
Floor 2, 63 Queen Victoria Street, EC4N 4UA
Tel: 0203 597 6361
Email: aqseregulation@aquis.eu
Website: www.aquis.eu/aquis-sto [ … ]
Thu, 06.06.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE
Vancouver, BC, Canada, June 6th, 2024 - Defence Therapeutics Inc. ( [ … ]
Thu, 06.06.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE
Vancouver, BC, Canada, June 6th, 2024 - Defence Therapeutics Inc. ( [ … ]
Thu, 06.06.2024
Leonteq AG
Leonteq AG
/ Key word(s): Alliance
Press release: Leonteq launches collaboration with neon
06.06.2024 / 07:00 CET/CEST
PRESS RELEASE | LEONTEQ LAUNCHES COLLABORATION WITH NEON
Zurich, 6 June 2024
Leonteq today announced the launch of a collaboration with neon under which neon will offer the ETP+ on the FuW Swiss 50 In [ … ]
Thu, 06.06.2024
RATIONAL AG
Rational AG is back in the MDAX and welcomes new members to the Supervisory Board
Landsberg am Lech, 6 June 2024 Deutsche Börse informed the capital market on the evening of 5 June 2024 that Rational was returning to the MDAX. “After our temporary absence, we look forward to being back in the MDAX and hence part of the DAX family again from 24 [ … ]
Thu, 06.06.2024
Highlight Event and Entertainment AG
Highlight Event and Entertainment AG
/ Key word(s): AGMEGM
Highlight Event and Entertainment AG publishes invitation to the Annual General meeting on 28 June 2024
06.06.2024 / 07:00 CET/CEST
PRESS RELEASE
Pratteln, June 6, 2024
Highlight Event and Entertainment AG publishes invitation to the Annual General meeting on [ … ]
Thu, 06.06.2024
Nemetschek SE
Nemetschek Group to Acquire GoCanvas to further Accelerate Digitalization in Construction Industry
GoCanvas is a leading provider of SaaS solutions for enhancing productivity and safety through paperless collection, reporting and integration of field data in construction
Perfect fit with Nemetschek’s Build & Construct Division portfolio stra [ … ]
Thu, 06.06.2024
Lalique Group SA
MEDIA RELEASE – Ad hoc announcement pursuant to Art. 53 LRMedia release (PDF)Medienmitteilung (PDF)Communiqué de presse (PDF)
Zurich, 6 June 2024 – Lalique Group SA (SIX: LLQ), which is active in the creation, development, marketing and worldwide distribution of luxury goods, today published the agenda for its Ordinary General Meeting of 28 June 20 [ … ]